Acanthosis Nigricans

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 9, Issue 2-4, 1998, Pages 407-418

  Stuart, Charles A ^a   Gilkison, Charles R ^a   Driscoll, Marcia S ^a   Lundquist, Kurt F ^a   Shaheb, Sudah ^b   Smith, Michele M ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b Winnebago Tribe of Nebraska   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOSIS NIGRICANS; AGE DISTRIBUTION; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HYPERINSULINEMIA; HYPERKERATOSIS; INSULIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PAPILLOMATOSIS; PATHOPHYSIOLOGY; RACE DIFFERENCE; REVIEW; RISK FACTOR;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; ANIMALS; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; MALE; MICE; OBESITY;

EID: 0032456222     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.1998.9.2-4.407     Document Type: Article

References (34)

1. Acanthosis nigricans. In: Rook A. Wilkinson DSD, Ebling FJG, editors. Textbook of Dermatology, 3rd Ed. Oxford: Blackwell Scientific, 1979; 1307–1310.
2. Brzechffa, PR, Jakimiuk, AJ, Agarwal, SK, Weitsman, SR, Buyalos, RP, Magoffin, DA. Serum inmunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81: 4166–4169.
3. Kahn, CR, Flier, JS, Bar, RS, Archer, JA, Gorden, P, Martin, MM, Roth, J. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med 1976; 294: 739–745.
4. Taylor, SI. Lilly Lecture: Molecular mechanisms of insulin resistance: Lessons from patients with mutations in the insulin-receptor gene. Diabetes 1992; 41: 1473–1490.
5. Stuart, CA, Pate, CJ, Peters, EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med 1989; 87: 269–272.
6. Stuart, CA, Smith, MM, Gilkison, CR, Shaheb, S, Stahn, RM. Acanthosis nigricans among Native Americans: An indicator of high diabetes risk. Am J Public Health 1994; 84: 1839–1842.
7. Stuart, CA, Gilkison, CR, Keenan, BS, Nagamani, M. Hyperinsulinemia and acanthosis nigricans m African Americans. J Natl Med Assoc 1997; 89: 523–527.
8. Stuart, CA, Peters, EJ, Prince, MJ, Richards, G. Cavallo, A. Meyer, WJ. Insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess. Metabolism 1986; 35: 197–205.
9. Stuart, CA, Gilkison, CR, Smith, MM, Bosma, AM, Keenan, BS, Nagamani, M. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. ClinPediatr 1998; 37: 73–80.
10. Fuchs, E. Epidermal differentiation: The bare essentials. J Cell Biol 1990; 111: 2807–2814.
11. Holbrook, KA, Wolff, K. Structure and development of skin. In: Fitzpatrick TB, Eisen AZ, Wolff K. Freedberg IM, Austen KF, eds. Dermatology in General Medicine, Fourth Ed. New York: McGraw-Hill, 1993; 97–145.
12. Finch, PW, Rubin, JS, Miki, T, Ron, D, Aaronson, SA. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989; 245: 752–755.
13. Neely, EK, Morhenn, VB, Hintz, RL, Wilson, DM, Rosenfeld, RG. Insulin-like growth factors are mitogenic for human keratinocytes and a squamous cell carcinoma. J Invest Dermatol 1991; 96: 104–110.
14. Batch, JA, Mercuri, FA, Edmondson, SR, Werther, GA. Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization. J Chn Endocrinol Metab 1994; 79: 1444–1449.
15. Flier, JS, Moller, DE, Moses, AC, O‘Rahilly, S. Chaiken, RL, Grigorescu, F, Elahi, D, Kahn, BB, Weinreb, JE, Eastman, R. Insulin-mediated pseudoacromegaly: Clinical and biochemical characterization of a syndrome of selective insulin resistance. J Clin Endocrinol Metab 1993; 76: 1533–1541.
16. Takahashi, Y, Tobe, K, Kadowaki, H, Katsumata, D, Fukushima, Y, Yazaki, Y, Akanuma, Y, Kadowaki, T. Roles of insulin receptor substrate-1 and She on insulin-like growth factor 1 receptor signaling in early passages of cultured human fibroblasts. Endocrinology 1997; 138: 741–750.
17. Murillas, R, Larcher, F, Conti, CJ, Santos, M, Ullrich, A, Jorcano, JL. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J 1995; 14: 5216–5223.
18. Liu, J-P, Baker, J, Perkins, AS, Robertson, EJ, Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor 1 (lgf-1) and type 1 IGF receptor (Igflr). Cell 1993; 75: 59–72.
19. LeRoith, D, Werner, H, Beitner-Johnson, D, Roberts, CT Jr. Molecular and cellular aspects of the insulin-like growth factor 1 receptor. Endocr Rev 1995; 16: 143–163.
20. Dunaif, A. Insulin resitance and the polycystic ovarj' syndrome: Mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774–800.
21. Brown, J, Winkelman, RK. Acanthosis nigricans: a study of 90 cases. Medicine 1968; 47: 33–51
22. Freymond, D, Bogardus, C, Okubo, M, Stone, K, Mott, D. Impaired insulin-stimulated muscle glycogen synthase activation in vivo in man is related to low fasting glycogen synthase phosphatase activity. J Clin Invest 1988; 82: 1503–1509.
23. Schweitzer, WJ, Goldin, HM. Bronson, DM, Brody, PE. Acanthosis nigricans associated with mycosis fungoides. J Am Acad Dermatol 1988; 19: 951–953.
24. McLean, Dl, Haynes, HA. Cutaneous manifestations of internal malignant disease. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in General Medicine, Fourth Ed. New York: McGraw-Hill, 1993; 2229–2249.
25. Dunaif, A, Graf, M, Mandeli, J, Laumas, V, Dobrjansky, A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 1987; 65:499–507.
26. Dunaif, A. Green, G. Phelps, RG, Lebwohl, M, Futterweit, W, Lewym, L. Acanthosis nigricans, insulin action, and hyperandrogenism: Clinical, histological, and biochemical findings. J Clin Endocrinol Metab 1991; 73: 590–595.
27. Richards, GE, Cavallo, A, Meyer, WJ, Prince, MJ, Peters, EJ, Stuart, CA, Smith, ER. Obesity, acanthosis nigricans, insulin resistance and hyperandrogen-emia: Pediatric perspective and natural history. J Pediatr 1985; 107: 893–897.
28. Peters, EJ, Stuart, CA, Prince, MJ. Acanthosis nigricans and obesity: Acquired and intrinsic defects in insulin action. Metabolism 1986; 35: 807–813.
29. Dowlati, B, Dunhardt, PA, Smith, MM, Shaheb, S, Stuart, CA. Quantification of insulin in dried blood spots. J Lab Clin Med 1998; 131: 370–374.
30. Taylor, SI, Accili, D, Imai, Y. Insulin resistance or insulin deficiency: Which is the primary cause of NIDDM? Diabetes 1994; 43: 735–740.
31. Beck-Nielsen, H, Groop, LC. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 1994; 94: 1714–1721.
32. Olefsky, JM, Farquhar, JW, Reaven, GM. Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes 1973; 22: 507–513.
33. Hollenbeck, CB, Chen, N, Chen, Y-D. Reaven, GM. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 1984; 33: 460–463.
34. Saad, MF, Anderson, RL, Laws, A, Watanabe, RM, Kades, WW, Chen, Y-DI, Sands, RE, Pei, D, Savage, PJ, Bergman, RN. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 1994; 43: 1114–1121.